Shingles Vaccine Generates Strong Immune Response in Patients With RA Receiving Upadacitinib
By week 16, researchers found 87.8% of patients achieved a satisfactory humoral response.
Previous Post
Nurses to be trained as ‘genomics champions’ under 10 year plan
Next Post
Optimizing Multiple Myeloma Treatment as Therapy Costs Rise: Matias Sanchez, MD
📢
Advertisement
300x250 Banner
Recent Content
COPD Biologics: Early Treatment Insights
Pulmonology • 2 hours ago
Antihypertensive Medication Guidelines
Cardiology • 4 hours ago
Juvenile Arthritis Care Transition
Rheumatology • 6 hours ago